title: Glial adenosine kinase--a neuropathological marker of the epileptic brain.
abstract: Experimental research over the past decade has supported the critical role of astrocytes activated by different types of injury and the pathophysiological processes that underlie the development of epilepsy. In both experimental and human epileptic tissues astrocytes undergo complex changes in their physiological properties, which can alter glio-neuronal communication, contributing to seizure precipitation and recurrence. In this context, understanding which of the molecular mechanisms are crucially involved in the regulation of glio-neuronal interactions under pathological conditions associated with seizure development is important to get more insight into the role of astrocytes in epilepsy. This article reviews current knowledge regarding the role of glial adenosine kinase as a neuropathological marker of the epileptic brain. Both experimental findings in clinically relevant models, as well as observations in drug-resistant human epilepsies will be discussed, highlighting the link between astrogliosis, dysfunction of adenosine homeostasis and seizure generation and therefore suggesting new strategies for targeting astrocyte-mediated epileptogenesis.
authors: Department (Neuro) Pathology, Academisch Medisch Centrum, Amsterdam, Heemstede, The Netherlands; Epilepsy Institute in The Netherlands Foundation (Stichting Epilepsie Instellingen Nederland, SEIN), Heemstede, The Netherlands.
authors: Eleonora
authors: E
authors: Aronica
authors: Ursula S
authors: US
authors: Sandau
authors: Anand
authors: A
authors: Iyer
authors: Detlev
authors: D
authors: Boison
mesh_terms: D000248:Adenosine Kinase / Q000378:metabolism*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D004827:Epilepsy / Q000378:metabolism*; D006801:Humans; D009457:Neuroglia / Q000201:enzymology*
chemical_list: D015415:Biomarkers; D000248:Adenosine Kinase
keywords: ADK; Astrocytes; Epilepsy; Human; Rodents
references: J Neurosci. 1993 Aug;13(8):3439-47
references: 8393482
references: Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):299-309
references: 11111825
references: Purinergic Signal. 2007 Mar;3(1-2):13-25
references: 18404415
references: J Neurosci. 2004 Jan 21;24(3):692-701
references: 14736855
references: J Chem Neuroanat. 2006 Apr;31(3):162-8
references: 16448802
references: Acta Neuropathol. 2010 Jan;119(1):7-35
references: 20012068
references: Glia. 2002 Aug;39(2):133-47
references: 12112365
references: Brain Pathol. 2012 May;22(3):380-401
references: 22497611
references: Neuroreport. 1991 Nov;2(11):661-4
references: 1667270
references: Eur J Neurosci. 2003 Aug;18(4):820-8
references: 12925008
references: Eur J Pharmacol. 2008 Oct 31;596(1-3):6-13
references: 18727925
references: Mol Endocrinol. 1991 Aug;5(8):1037-48
references: 1658635
references: Epilepsia. 2012 Jan;53(1):58-66
references: 22092111
references: J Neurosci Res. 1994 Jul 1;38(4):399-406
references: 7932872
references: Ann Neurol. 1991 May;29(5):575
references: 1859190
references: J Neurosci. 2012 Apr 11;32(15):5321-32
references: 22496577
references: Prog Neurobiol. 2008 Mar;84(3):249-62
references: 18249058
references: Pflugers Arch. 2004 Feb;447(5):735-43
references: 12838422
references: Glia. 2006 Oct;54(5):358-68
references: 16886201
references: Glia. 2003 Aug;43(2):190-4
references: 12838511
references: Neuron. 1997 Sep;19(3):687-95
references: 9331358
references: Lancet Neurol. 2007 May;6(5):421-30
references: 17434097
references: Curr Top Med Chem. 2011;11(8):1068-86
references: 21401494
references: Arch Neurol. 2009 Apr;66(4):435-40
references: 19204149
references: Ann Neurol. 1992 Nov;32(5):618-24
references: 1449242
references: Neuropharmacology. 2009 Feb;56(2):429-37
references: 18957298
references: Brain Res Rev. 2010 May;63(1-2):212-21
references: 19883685
references: J Neurosci. 2010 Sep 29;30(39):13157-65
references: 20881134
references: Exp Neurol. 2006 Jul;200(1):184-90
references: 16750195
references: Neuron Glia Biol. 2007 Nov;3(4):353-66
references: 18634566
references: Epilepsy Res. 2009 Aug;85(2-3):131-41
references: 19428218
references: Exp Neurol. 2013 Jun;244:4-10
references: 21925173
references: Exp Neurol. 2007 Nov;208(1):26-37
references: 17716659
references: Lancet Neurol. 2003 Jun;2(6):366-74
references: 12849153
references: Life Sci. 2001 Feb 9;68(12):1343-50
references: 11388687
references: J Neurooncol. 2007 Oct;85(1):49-63
references: 17497078
references: Neuroscience. 2009 Sep 29;163(1):490-9
references: 19345722
references: J Neurosci. 2006 Oct 25;26(43):11083-110
references: 17065450
references: J Cereb Blood Flow Metab. 2008 Jan;28(1):17-23
references: 17457365
references: Cell Death Differ. 2010 Jul;17(7):1071-82
references: 19763139
references: J Clin Invest. 2008 Feb;118(2):571-82
references: 18172552
references: J Physiol. 2002 Feb 15;539(Pt 1):67-75
references: 11850502
references: J Comp Neurol. 1998 Nov 16;401(2):163-86
references: 9822147
references: J Neurosci Res. 1994 Dec 1;39(5):556-66
references: 7891391
references: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15735-40
references: 9861039
references: Methods Mol Biol. 2010;650:225-40
references: 20686955
references: J Neurochem. 2011 Apr;117(1):100-11
references: 21235574
references: Epilepsia. 1980 Oct;21(5):541-8
references: 7418669
references: Neuron. 2003 Dec 4;40(5):971-82
references: 14659095
references: Lancet. 2001 Aug 11;358(9280):461-7
references: 11513911
references: Exp Neurol. 2009 Sep;219(1):126-35
references: 19460372
references: Glia. 2005 Oct;52(1):25-35
references: 15892125
references: Exp Neurol. 2013 Jun;244:11-21
references: 21985866
references: Neuroreport. 2004 Jul 19;15(10):1585-9
references: 15232288
references: J Neurosci. 2004 Feb 11;24(6):1521-9
references: 14960625
references: Trends Pharmacol Sci. 2005 Oct;26(10):511-6
references: 16125796
references: Purinergic Signal. 2012 Feb;8(Suppl 1):91-9
references: 22081230
references: Epilepsy Res. 2009 Apr;84(2-3):238-41
references: 19217263
references: Brain. 2005 Oct;128(Pt 10):2383-95
references: 15930047
references: Brain Pathol. 2012 May;22(3):350-79
references: 22497610
references: Epilepsia. 2005;46 Suppl 5:159-65
references: 15987272
references: Science. 2005 Oct 7;310(5745):113-6
references: 16210541
references: Epilepsia. 2011 Mar;52(3):589-601
references: 21275977
references: Annu Rev Pharmacol Toxicol. 2005;45:385-412
references: 15822182
references: Neuroscience. 2006 Sep 29;142(1):125-37
references: 16859834
references: Glia. 2012 Jan;60(1):83-95
references: 21964979
references: Mol Pharmacol. 2007 May;71(5):1369-80
references: 17293559
references: Purinergic Signal. 2005 Jun;1(2):111-34
references: 18404497
references: Biochem Biophys Res Commun. 1997 Dec 18;241(2):297-304
references: 9425266
references: Drug News Perspect. 2003 Jun;16(5):283-9
references: 12942159
references: Epilepsia. 2011 May;52 Suppl 3:26-32
references: 21542843
references: Brain. 2007 May;130(Pt 5):1276-88
references: 17472985
references: Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6265-70
references: 22421436
references: J Biol Chem. 1994 Jul 8;269(27):17820-5
references: 8027035
references: Epilepsia. 2003 Jul;44(7):877-85
references: 12823569
references: Trends Pharmacol Sci. 1988 Jun;9(6):193-4
references: 3073553
references: Nat Rev Drug Discov. 2006 Mar;5(3):247-64
references: 16518376
references: Biochem Pharmacol. 2010 May 15;79(10):1483-95
references: 20096265
references: Neuropharmacology. 2012 Mar;62(3):1527-43
references: 21315743
references: J Physiol. 2007 Jul 1;582(Pt 1):263-77
references: 17478533
references: J Cereb Blood Flow Metab. 2007 Jan;27(1):1-5
references: 16685255
references: Biochem Biophys Res Commun. 2009 Oct 9;388(1):46-50
references: 19635462
references: J Neurochem. 2004 Aug;90(4):883-93
references: 15287894
references: Biochim Biophys Acta. 2011 May;1808(5):1400-12
references: 20888788
references: Curr Neuropharmacol. 2009 Sep;7(3):180-94
references: 20190960
references: Neuron Glia Biol. 2008 May;4(2):91-9
references: 19674507
references: Neurotoxicology. 2006 Jul;27(4):458-67
references: 16469385
references: Open Neurosci J. 2010 Jan 1;4:93-101
references: 20730044
references: Biochim Biophys Acta. 2011 May;1808(5):1380-99
references: 21145878
references: J Clin Invest. 2011 Jul;121(7):2679-83
references: 21701065
references: Epilepsia. 2011 Sep;52(9):1645-55
references: 21635241
references: Cancer Res. 2006 Sep 1;66(17):8550-7
references: 16951167
references: Acta Neuropathol. 2009 May;117(5):535-44
references: 19277686
references: Science. 1994 Sep 30;265(5181):2098-101
references: 7916485
references: Prog Neurobiol. 2007 Dec;83(5):332-47
references: 17532111
references: Int Rev Neurobiol. 2005;63:191-270
references: 15797469
references: Glia. 2012 Aug;60(8):1258-68
references: 22331574
references: Brain Pathol. 2009 Oct;19(4):565-72
references: 18761661
references: Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):750-4
references: 18600536
references: Handb Exp Pharmacol. 2009;(193):471-534
references: 19639292
references: Annu Rev Neurosci. 2001;24:31-55
references: 11283304
references: Trends Pharmacol Sci. 2006 Dec;27(12):652-8
references: 17056128
references: Biomaterials. 2008 Sep;29(26):3609-16
references: 18514814
references: J Neurosci. 2008 Apr 30;28(18):4702-11
references: 18448647
references: FEBS Lett. 1998 Jun 12;429(2):139-42
references: 9650577
references: Pflugers Arch. 2004 Feb;447(5):728-34
references: 12856181
references: Neurosci Lett. 2000 Apr 21;284(1-2):49-52
references: 10771159
references: Neurosci Lett. 2007 May 11;418(1):66-71
references: 17400382
references: Methods Mol Biol. 2011;670:1-9
references: 20967579
references: Neuron. 2008 Apr 24;58(2):168-78
references: 18439402
references: Neurobiol Aging. 2004 May-Jun;25(5):663-74
references: 15172746